Cargando…

Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma

BACKGROUND: Immunotherapy is one of the research hotspots in the field of hepatocellular carcinoma (HCC). Successive clinical trials have shown that patients with CTNNB1 mutations are resistant to immunotherapy, but the mechanism is still unclear. MATERIAL/METHODS: We identified differentially expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huo, Junyu, Wu, Liqun, Zang, Yunjin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Database Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523420/ https://www.ncbi.nlm.nih.gov/pubmed/32945289 http://dx.doi.org/10.12659/MSM.925494

Ejemplares similares

Development and validation of a CTNNB1‐associated metabolic prognostic model for hepatocellular carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

An Individualized Immune Prognostic Index is a Superior Predictor of Survival of Hepatocellular Carcinoma
por: Wang, Xiaodong, et al.
Publicado: (2020)

Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer
por: Huo, Junyu, et al.
Publicado: (2021)

Construction and Validation of a 7-Immune Gene Model for Prognostic Assessment of Esophageal Carcinoma
por: Chen, Haitao, et al.
Publicado: (2020)

CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Zou, Yiping, et al.
Publicado: (2020)

Integrated Analysis of Angiogenesis-Mediated Tumor Immune Microenvironment Pattern in Hepatocellular Carcinoma (HCC) and a Novel Prognostic Model Construction to Predict Patient Outcome
por: Lv, Chengqian, et al.
Publicado: (2021)

Construction and Validation of a Universal Applicable Prognostic Signature for Gastric Cancer Based on Seven Immune-Related Gene Correlated With Tumor Associated Macrophages
por: Huo, Junyu, et al.
Publicado: (2021)

Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Tian, Zongbiao, et al.
Publicado: (2020)

Development and Validation of a 5-Gene Autophagy-Based Prognostic Index in Endometrial Carcinoma
por: Chen, Xiaoyan, et al.
Publicado: (2021)

Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular Carcinoma
por: Liu, Zhikun, et al.
Publicado: (2021)

Eleven immune-gene pairs signature associated with TP53 predicting the overall survival of gastric cancer: a retrospective analysis of large sample and multicenter from public database
por: Huo, Junyu, et al.
Publicado: (2021)

Development and Validation of a Novel Metabolic-Related Signature Predicting Overall Survival for Pancreatic Cancer
por: Huo, Junyu, et al.
Publicado: (2021)

Identification of an Immune Score-Based Gene Panel with Prognostic Power for Oral Squamous Cell Carcinoma
por: Huang, Su-Ning, et al.
Publicado: (2020)

Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes
por: Mo, Bin-Yu, et al.
Publicado: (2020)

RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance
por: Zhao, Hua, et al.
Publicado: (2021)

Development and Validation of Prognostic Nomograms for Patients with Duodenal Neuroendocrine Neoplasms
por: Sun, Shenghong, et al.
Publicado: (2020)

Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells
por: Hu, Chuan, et al.
Publicado: (2020)

Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma
por: Wang, Lan-Lan, et al.
Publicado: (2021)

NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma
por: Li, Zigang, et al.
Publicado: (2023)

Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment
por: Sun, Mengyu, et al.
Publicado: (2020)

Expression and Prognostic Significance of Cadherin 4 (CDH4) in Renal Cell Carcinoma
por: Zhou, Xiaohui, et al.
Publicado: (2020)

Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics
por: Kou, Yan-qi, et al.
Publicado: (2023)

Prognostic Value of SLC4A4 and its Correlation with Immune Infiltration in Colon Adenocarcinoma
por: Chen, Xiaoli, et al.
Publicado: (2020)

The Prognostic Role of Glutathione Peroxidase 1 and Immune Infiltrates in Glioma Investigated Using Public Datasets
por: Lv, Shigang, et al.
Publicado: (2020)

A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer
por: Lin, Yun, et al.
Publicado: (2023)

Identification of Potential Prognostic and Predictive Biomarkers for Immune-Checkpoint Inhibitor Response in Small Cell Lung Cancer
por: Gao, Chanchan, et al.
Publicado: (2021)

High SPATA18 Expression and its Diagnostic and Prognostic Value in Clear Cell Renal Cell Carcinoma
por: Lingui, Xie, et al.
Publicado: (2023)

Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma
por: Feng, Chen, et al.
Publicado: (2020)

Identification of Therapeutic and Prognostic Biomarkers of Lamin C (LAMC) Family Members in Head and Neck Squamous Cell Carcinoma
por: Jiang, Pan, et al.
Publicado: (2020)

Overexpression of Apolipoprotein C1 (APOC1) in Clear Cell Renal Cell Carcinoma and Its Prognostic Significance
por: Xiao, Huaying, et al.
Publicado: (2021)

Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma
por: Zhao, Xuemiao, et al.
Publicado: (2021)

H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation
por: Li, Zongkuo, et al.
Publicado: (2022)

H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro
por: Luo, Min, et al.
Publicado: (2021)

Novel Prognostic Model for Gastric Cancer using 13 Co-Expression Long Non-Coding RNAs (LncRNAs)
por: Luo, Xi, et al.
Publicado: (2020)

MS4A1 as a Potential Independent Prognostic Factor of Breast Cancer Related to Lipid Metabolism and Immune Microenvironment Based on TCGA Database Analysis
por: Li, Shilin, et al.
Publicado: (2022)

Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in Breast Cancer
por: Yi, Weiwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8g2tph421lfvaj23v1kecaco3d